Get the Stockscreener App
0.3507
8.55%
-0.0328
Pre-market:
.36
0.0093
+2.65%
Jupiter Neurosciences Inc stock is traded at $0.3507, with a volume of 108.38K.
It is down -8.55% in the last 24 hours and down -41.81% over the past month.
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
See More
Previous Close:
$0.3835
Open:
$0.3806
24h Volume:
108.38K
Relative Volume:
0.35
Market Cap:
$12.07M
Revenue:
-
Net Income/Loss:
$-7.60M
P/E Ratio:
-1.5422
EPS:
-0.2274
Net Cash Flow:
$-6.74M
1W Performance:
-5.22%
1M Performance:
-41.81%
6M Performance:
-74.95%
1Y Performance:
-51.77%
1-Day Range:
$0.3501
$0.3987
1-Week Range:
$0.33
$0.43
52-Week Range:
$0.33
$3.33
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Name
Jupiter Neurosciences Inc
Sector
Industry
Phone
(561) 406-6154
Address
1001 NORTH US HWY 1, JUPITER
Compare JUNS vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
0.3507 | 12.07M | 0 | -7.60M | -6.74M | -0.2274 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Jupiter Neurosciences Inc Stock (JUNS) Latest News
Trading Action: Can Jupiter Neurosciences Inc reach all time highs this yearFed Meeting & Daily Growth Stock Investment Tips - baoquankhu1.vn
Aug Patterns: Is Jupiter Neurosciences Inc benefiting from interest rate changesShort Setup & Long-Term Safe Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
If You Invested $1,000 in JUPITER NEUROSCIENCES, INC. (JUNS) - Stock Titan
Will Jupiter Neurosciences Inc benefit from geopolitical trendsMarket Risk Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Jupiter Neurosciences, Inc.: Fundamental Analysis and Financial Ratings | JUNS | US48208B2034 - marketscreener.com
JUNS Forecast, Price Target & Analyst Ratings | JUPITER NEUROSCIENCES INC (NASDAQ:JUNS) - ChartMill
CEO Moves: Is Jupiter Neurosciences Inc benefiting from interest rate changesWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Market Overview: Can Jupiter Neurosciences Inc. reach all time highs this yearGap Up & Scalable Portfolio Growth Methods - baoquankhu1.vn
Trading Action: Is Jupiter Neurosciences Inc forming a double bottomMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Bull Bear: What is the earnings history of Jupiter Neurosciences IncTrend Reversal & Technical Buy Zone Confirmations - baoquankhu1.vn
Momentum Shift: How do insiders feel about Jupiter Neurosciences IncJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Buyback Watch: Will Jupiter Neurosciences Inc face regulatory challengesJuly 2025 Big Picture & Daily Profit Focused Screening - baoquankhu1.vn
Aug Rallies: Can Jupiter Neurosciences Inc scale operations efficientlyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - baoquankhu1.vn
JUNS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 - mydailyrecord.com
Parkinson’s trial and Nugevia revenue put Jupiter Neurosciences on BIO stage - Stock Titan
JUNS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting - TipRanks
Jupiter Neurosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jupiter Neurosciences (JUNS) faces Nasdaq bid price and $35M value shortfall - Stock Titan
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago - BioSpace
Chipmakers Recap: Does Sun Life Financial Inc stock have upside surprise potentialWeekly Trade Analysis & Consistent Return Strategy Ideas - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution - Delawareonline.com
Yorkville defers $6M to 2026 as Jupiter pushes Nugevia sales, Parkinson’s program - Stock Titan
JUNSJUPITER NEUROSCIENCES, INC. Latest Stock News & Market Updates - Stock Titan
Aug PostEarnings: How sensitive is HSTM to inflationTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Financing Agreement Terms - TipRanks
Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsMarket Rally & AI Forecasted Entry and Exit Points - mfd.ru
What is the earnings history of Jupiter Neurosciences Inc.Trade Entry Report & Weekly Watchlist for Consistent Profits - mfd.ru
Jupiter Neuroscience and ANNIKA Women’s All Pro Tour Announce Multi-Year Partnership - The Golf Wire
Can Jupiter Neurosciences Inc reach resistance levels soon2025 Dividend Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Big Picture: What is the next catalyst for Jupiter Neurosciences Inc.July 2025 Drop Watch & Reliable Breakout Stock Forecasts - mfd.ru
Aug Wrap: Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsInsider Selling & Long-Term Growth Plans - mfd.ru
Analyst Upgrade: Should I average down on PTPI stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company - The Progress Index
Can Jupiter Neurosciences Inc. reach all time highs this year2025 Retail Activity & Growth Oriented Trading Recommendations - mfd.ru
Jupiter Neurosciences Selected as B2i Digital Featured Company Amid Parkinson's Trial and Consumer Brand Expansion - citybuzz -
Signal Recap: What analysts say about Jupiter Neurosciences Inc stockWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company | Corporate - EQS News
Will Jupiter Neurosciences Inc. stock attract more institutional investors2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Travel Stocks: Is Jupiter Neurosciences Inc currently under institutional pressureTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Analyst Calls: Is Jupiter Neurosciences Inc in a long term uptrendJuly 2025 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Will Cineverse Corp outperform tech stocksM&A Rumor & Weekly High Return Stock Forecasts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users - The Desert Sun
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Gains Recap: Does Verde Clean Fuels Inc. have strong EBITDA marginsMarket Weekly Review & AI Forecasted Stock Moves - baoquankhu1.vn
Jupiter Neurosciences launches support initiative for GLP-1 users By Investing.com - Investing.com Nigeria
Jupiter Neurosciences Expands Nugevia™ Addressable Market With Focus On GLP-1 Users - Tampa Free Press
Portfolio Recap: What analysts say about ALCY stockCPI Data & Community Verified Watchlist Alerts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users - marketscreener.com
Jupiter Neurosciences Inc Stock (JUNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):